Holen Sie sich die Stockscreener-App
0.546
19.94%
-0.136
Handel nachbörslich:
.56
0.014
+2.56%
Schlusskurs vom Vortag:
$0.682
Offen:
$0.727
24-Stunden-Volumen:
293.58K
Relative Volume:
10.73
Marktkapitalisierung:
$2.95M
Einnahmen:
$1.20M
Nettoeinkommen (Verlust:
$-2.82M
KGV:
-0.201
EPS:
-2.7164
Netto-Cashflow:
$-7.73M
1W Leistung:
-57.67%
1M Leistung:
-68.07%
6M Leistung:
-88.51%
1J Leistung:
-67.50%
1-Tages-Spanne:
$0.46
$0.73
1-Wochen-Bereich:
$0.46
$1.29
52-Wochen-Spanne:
$0.46
$17.49
Aptorum Group Ltd Stock (APM) Company Profile
Firmenname
Aptorum Group Ltd
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie APM mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| APM | 0.546 | 2.95M | 1.20M | -2.82M | -7.73M | -2.7164 |
| VRTX | 467.01 | 119.87B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 762.00 | 83.27B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 567.90 | 33.96B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 232.27 | 30.18B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 101.87 | 24.42B | 3.30B | -501.07M | 1.03B | 11.54 |
Aptorum Group Ltd Aktie (APM) Neueste Nachrichten
Aptorum Group Stock Hits 52-Week Low at $1.2 Amid Market Challenges - Investing.com Canada
Aptorum Group announces annual shareholder meeting details By Investing.com - Investing.com Australia
Aptorum Group announces annual shareholder meeting details - Investing.com India
Aptorum stock hits 52-week low at $1.34 amid market challenges - Investing.com India
Oil prices soar after OPEC+ delays production hike - Investing.com
Andean Precious Metals (CVE:APM) Upgraded at Desjardins - Defense World
Aptorum Group stock hits 52-week low at $1.35 amid market challenges - Investing.com Australia
Aptorum Group to Hold Investor Webinar and Present at The Wall Street Investor Forum on September 10 - AsiaOne
Andean Precious Metals (CVE:APM) Reaches New 1-Year High Following Insider Buying Activity - MarketBeat
Oncology And Infectious Diseases Focused Aptorum Stock Skyrockets 7X On WednesdayHere's Why - MSN
Aptorum Group Limited (NASDAQ:APM) Sees Large Growth in Short Interest - Defense World
Aptorum Group Limited (NASDAQ:APM) Short Interest Down 47.1% in July - Defense World
Aptorum Group Limited (NASDAQ:APM) Short Interest Update - Defense World
NASDAQ – Stock Price, Charts & News Today - BNN Bloomberg
Aptorum Group (NASDAQ:APM) Trading Up 0.4% - Defense World
Aptorum Group Limited Reports 2023 Fiscal Year End Financial Results and Provides Business Update30.04.2024 - wallstreet:online
Why Lifecore Biomedical Shares Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session - Markets Insider
symbol__ Stock Quote Price and Forecast - CNN
Why Limbach Holdings Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session - Markets Insider
Nasdaq Rises 100 Points; BJ's Wholesale Posts Weak Sales - Benzinga
Aptorum Group Ltd Announces Entering into an Agreement and Plan of Merger with YOOV Group Holding Ltd and a ... - sharewise
Aptorum and YOOV announce merger plan - Investing.com
Aptorum Group Limited to Hold Annual General Meeting of Shareholders on December 20, 2023 - Business Wire
Aptorum Group Receives Nasdaq Approval to Transfer Listing to Nasdaq Capital Markets - Yahoo Finance
Aptorum Group Limited Announces Resignation of Thomas Lee as Head of Research and Development - Marketscreener.com
Why Is Aptorum (APM) Stock Down 16% Today? - InvestorPlace
Aptorum Group Enters into Letter of Intent and Term Sheet To Acquire U Group - Business Wire
Menopause Market Size, Share And Trends Report, 2031 - SkyQuest Technology
Aptorum Group Announces 1-for-10 Reverse Stock Split - Business Wire
Cotações de Ações Americanas (STOCKS) - Money Times
DelveInsight Estimates a Promising Picture of Obesity Pipeline Space Landscape as Key 100+ Pharma Companies Working in the Space - PR Newswire
Aptorum Group Updates on the Clinical Validation of RPIDD Infectious Disease Liquid Biopsy Molecular Diagnostics - ACROFAN
Notice to Boustead Securities Customers Who Purchased IPOs - GlobeNewswire
Aptorum Group Limited to Hold Annual General Meeting of Shareholders on December 2, 2021 - Business Wire
Aptorum GroupAPMHigh RIsk Biotech Stocks Buy, Sell, Hold Investing Analysis for the Long-run - The Market Oracle
NY-APTORUM-GROUP-LIMITED | Business Wire - Via Ritzau
Aptorum Gr (NASDAQ:APM) Stock Quotes, Forecast and News Summary - Benzinga
The Daily Biotech Pulse: FDA Greenlights Merck's Heart Failure Drug, Histogen Hit With Clinical Hold, Aptorum Gets Nod For Commencing Human Study - Markets Insider
42 Stocks Moving in Thursday's Pre-Market SessionC3.ai (NYSE:AI) - Benzinga
40 Stocks Moving in Monday's Pre-Market SessionAMC Enter Hldgs (NYSE:AMC), Aptorum Gr (NASDAQ:APM) - Benzinga
Aptorum Group Limited to Hold Annual General Meeting of Shareholders on December 9, 2020 - businesswire.com
Aptorum Group Limited (NASDAQ:APM) Unveils Infectious Disease Liquid Biopsy Subsidiary to Co-develop RPIDD Tech - BP Journal
45 Stocks Moving in Wednesday's Pre-Market SessionAdial Pharmaceuticals (NASDAQ:ADIL), Aptorum Gr (NAS - Benzinga
Aptorum Group Launches Infectious Disease Liquid Biopsy Subsidiary Start-up and Exclusively In-licensed from Singapore based Accelerate Technologies To Co-Develop Molecular Based Rapid Pathogen Diagnostics Technology To Track Pathogenic Geno - AsiaOne
Aptorum Group Ltd (NASDAQ:APM) Pleased To Unveil Video Indicating Positive Results On SACT-1 - BP Journal
Aptorum Group Announces Further Positive Data on ALS-4 against MRSA Wound Infection and MRSA Bacteraemia against Linezolid and Vancomycin Respectively in In Vivo Models - Business Wire
Sharp thinking in medicine | The Standard - Hong Kong Standard
Yam for maam: Aptorum Group to launch women’s bone health supplement made from Chinese yam - NutraIngredients-Asia
Aptorum Group Announces Significant Progress of Repurposed Drug Candidate, SACT-1 for Neuroblastoma Targeting IND Submission in H2 2020 - AsiaOne
Aeneas Capital and Pyrinas Target Launch of US$120m Fund to Develop Co-Working Laboratory Ecosystems for Life Sciences Start-Ups in the United States - BioSpace
Argus Research Initiates Equity Research Report Coverage on Aptorum Group Limited (NasdaqGM: APM) - GlobeNewswire
Finanzdaten der Aptorum Group Ltd-Aktie (APM)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.66%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):